GSA Capital Partners’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Other funds holding RCKT
NM
GSA Capital Partners's RCKT Position: Q3 2026 in Review
GSA Capital Partners opened a new position in Rocket Pharmaceuticals (RCKT) in Q3 2026: 15,088 shares worth $40K. The stake represents ﹤0.01% of the portfolio and ranks #1787 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in RCKT as recently as Q4 2025.
GSA Capital Partners first reported a position in RCKT in Q1 2017 and has held it in 14 quarters since. The position peaked at $871K in Q3 2022. 175 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.
- GSA Capital Partners held 15,088 shares of Rocket Pharmaceuticals worth $40K as of Q3 2026.
- Rocket Pharmaceuticals was a new GSA Capital Partners position in Q3 2026.
- Rocket Pharmaceuticals made up ﹤0.01% of GSA Capital Partners's portfolio in Q3 2026, its #1787 holding.
- GSA Capital Partners first reported a position in Rocket Pharmaceuticals in Q1 2017 and has held it in 14 quarters since.
- GSA Capital Partners's Rocket Pharmaceuticals position peaked at $871K in Q3 2022.
- 175 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.
Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.